What drugs does EUROHLTH INTL SARL make?

EUROHLTH INTL SARL has 3 FDA-approved drugs.

What therapeutic areas does EUROHLTH INTL SARL focus on?

EUROHLTH INTL SARL focuses primarily on Infectious Disease and Oncology.

Data updated: Mar 10, 2026

EUROHLTH INTL SARL

Infectious DiseaseOncology

Generics

EUROHLTH INTL SARL is a generic drug manufacturer focused on Infectious Disease, Oncology. Key products include AZACITIDINE.

1997

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

AZACITIDINE 2025-07-01

Labeling

AZACITIDINE 2025-07-01

Labeling

AZACITIDINE 2025-05-20

AZACITIDINE 2025-04-29

Labeling

AZACITIDINE 2025-04-29

Labeling

ACYCLOVIR SODIUM 2025-02-18

Labeling

AZACITIDINE 2025-01-24

Labeling

AZACITIDINE 2024-12-23

Labeling

AZACITIDINE 2024-12-23

Labeling

AZACITIDINE 2024-12-23

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%

1 drugs

Oncology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Oncology, Infectious Disease

Merck big-pharma

Oncology, Infectious Disease

Baxter specialty

Infectious Disease, Oncology

AbbVie big-pharma

Oncology, Infectious Disease

Johnson & Johnson big-pharma

Oncology, Infectious Disease

EUROHLTH INTL SARL

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (3)

Active (2)

Discontinued (1)

Company Info